Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

Spero announces GSK resubmission of NDA for tebipenem HBr to treat cUTI

Spero Therapeutics (NASDAQ:SPRO) announced today that its development partner, GSK (NYSE:GSK), has resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, a treatment for complicated urinary tract infections (cUTI), including pyelonephritis.

Leia mais: Spero announces GSK resubmission of NDA for tebipenem HBr to treat cUTI
Grafa
Health

Psyence BioMed receives ethics approval for psilocybin trial in cancer patients

Psyence BioMed (NASDAQ:PBM) announced that it has received approval from the Bellberry Human Research Ethics Committee to use its psilocybin product, NPX5, in its ongoing Phase IIb clinical trial for adjustment disorder in cancer patients.

Leia mais: Psyence BioMed receives ethics approval for psilocybin trial in cancer patients
Grafa

Parsons awarded $100M task order for new rocket motor facility in Florida

Parsons Corporation (NYSE:PSN) announced today that it has been awarded a task order exceeding $100 million by Nammo to provide design, program, and construction management (PM/CM) services for a new rocket motor manufacturing facility in Perry, Florida.

Leia mais: Parsons awarded $100M task order for new rocket motor facility in Florida